| Abstract | Decisions to begin or continue hormone replacement therapy (HRT) are individualized, depending on a woman's anticipated benefits and risks from HRT. Estrogen, especially when begun early in menopause, has been shown to be beneficial in the prevention and treatment of osteoporosis. Potential risks of HRT include gallbladder disease, thromboembolism, and breast cancer. Systemic or topical estrogen can improve postmenopausal vaginal atrophy, vasomotor symptoms, and cervical cytologic changes. Treatment of other urogynecologic changes, such as vulval dystrophy and urinary incontinence, can relieve symptoms and improve the older woman's quality of life. |
| Authors | B J Messinger-Rapport, H L Thacker
(Affiliation: Case Western Reserve University School of Medicine, Section of Gehatrics, Cleveland Clinic Foundation, Cleveland, OH, USA.)
|
| Journal | Geriatrics
(Geriatrics)
Vol. 56
Issue 9
Pg. 32-4, 37-8, 40-2
(Sep 2001)
ISSN: 0016-867X United States |
| PMID | 11582972
(Publication Type: Journal Article, Review)
|
| Topics |
- Administration, Topical
- Aged
- Aged, 80 and over
- Estrogen Replacement Therapy
(adverse effects)
- Female
- Humans
- Menopause
- Patient Selection
- Urinary Incontinence
(prevention & control, therapy)
- Urinary Tract Infections
(prevention & control, therapy)
|
